CDKN2A and pancreatic neoplasm: Additionally, CDKN2A encoding p16 and TP53 are frequently mutated in pancreatic cancer (>50% and 60–70%, respectively), leading to an uncontrolled cell cycle and bypass of DNA damage repair15.